A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: Timing is important

American Journal of Surgery

Volumn 190, Issue 4, 2005, Pages 517-520

  Jones, Julie L ^a   Zabicki, Katherina ^a,b   Christian, Roger L ^b   Gadd, Michele A ^a   Hughes, Kevin S ^a   Lesnikoski, Beth A ^b   Rhei, Esther ^b   Specht, Michelle C ^a   Dominguez, Francisco J ^a   Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXYCYCLINE; PACLITAXEL; TRASTUZUMAB;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ERROR; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 24944545237     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.06.004     Document Type: Conference Paper

References (12)

1. N. Wolmark, J. Wang, E. Mamounas Preoperative chemotherapy in patients with operable breast cancer nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 30 2001 96 102
2. B. Fisher, A. Brown, E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer findings from National Surgical Adjuvant Breast and Bowen Project B-18 J Clin Oncol 15 1997 2483 2493
3. A. Makris, T.J. Powles, S.E. Ashley A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1998 1179 1184
4. G.F. Schwartz, C.A. Birchansky, L.T. Komarrnicky Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast Cancer 73 1994 362 369
5. G. Bonadonna, P. Valagussa, C. Brambilla Primary chemotherapy in operable breast cancer eight-year experience at the Milan Cancer Institute J Clin Oncol 16 1998 93 100
6. G. Vlastos, N.Q. Mirza, J.T. Lenert The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy Cancer 88 2000 1417 1424
7. G. Calais, C. Berger, P. Descamps Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm Cancer 74 1994 1283 1288
8. H.M. Kuerer, A.A. Sahin, K.K. Hunt Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg 230 1999 72 78
9. J.L. Jones, E. Rhei, M.A. Gadd Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer (abstr). Presented at the American Society of Clinical Oncology, New Orleans, LA 2004
10. E.P. Mamounas, A. Brown, Anderson Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 23 2005 2694 2702
11. J.E. Lang, L.J. Esserman, C.A. Ewing Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy effect of clinical node status at presentation Am Coll Surg 199 2004 856 862
12. G.F. Schwartz, A.E. Giuliano, U. Veronesi Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. April 2001, Philadelphia, PA Hum Pathol 33 2002 579 589